Cannabis Suisse Corp
DIETIKON, SWITZERLAND / ACCESSWIRE / July 15, 2021 / Cannabis Suisse Corp. (OTC PINK:CSUI), a Nevada incorporated distribution company for recreational cannabis products and CBD oils, announces the results of laboratory testing of its new product line created for the upcoming launch on Shopify.
This news follows a recent announcement on the decision to choose ACS Laboratory as a CBD laboratory for testing the first shipment of the new Swiss4Life CBD brand, created for the launch of an online store on Shopify platform. The samples of products were sent to ACS laboratory to obtain СOA proving the quality of the new brand name CBD oils to the potential customers.
The certificates are ready for all the six types of current products: THC Free CBD Oil (Cherry Vanilla and Creme de Menthe) and CBD Tinctures with different therapeutic effects.
THC Free CBD Oil 1500 mg Cherry Vanilla has 1,521.586mg of Cannabinoids total (5.376%). 5.096% (1,442.211mg) are represented by CBD, 0.131% (36.992mg) are CBG, 0.051% (14.474mg) are CBN. The number of other Cannabinoids is 0.099% (27.909mg). THC is not detected.
THC Free CBD Oil 2500 mg Creme de Menthe contains 2,458.295mg of Cannabinoids total (8.654%). 8.177% (2,322.842mg) are represented by CBD, 0.209% (59.457mg) are CBG, 0.098% (27.851mg) are CBN. The number of other Cannabinoids is 0.169% (48.145mg). THC is not detected.
THC Free CBD Oil 3500 mg Cherry Vanilla has 3,513.119mg of Cannabinoids total (12.299%). 11.770% (3,362.096mg) are represented by CBD, 0.275% (78.554mg) are CBG, 0.115% (32.821mg) are CBN. The number of other Cannabinoids is 0.139% (39.648mg). THC is not detected.
CBD TINCTURES Anti-Inflammatory/Pain Relief/Focus contains 934.326mg of Cannabinoids total (3.328%). 3.314% (930.404mg) are represented by CBD, THC is not detected.
CBD TINCTURES Anti-Inflammatory/Pain Relief/Anti-Stress Formula has 920.788mg of Cannabinoids total (3.652%). 3.632% (915.728mg) are represented by CBD, THC is not detected.
CBD TINCTURES Natural Sleep Formula contains 913.149mg of Cannabinoids total (3.331%). 3.331% (913.149mg) are represented by CBD, other Cannabinoids or THC are not detected.
Since the Company received the certificates of analysis, a special page has been created on the site in the "LEARN" section so that users can see them at any time on their own and make sure of their authenticity. The COA were uploaded there along with the testing date.
ABOUT CANNABIS SUISSE CORP.
Cannabis Suisse Corp. is a public US Company incorporated in Nevada state. The Company operates in the field of distribution of recreational cannabis products and CBD oils. Cannabis Suisse Corp. currently sells via a distribution network of retailers and online shops, under the retail brand Swiss4Life. Swiss4Life products are made of USA hemp only and contain no THC, GMO or Gluten. They have not been evaluated by the FDA and are not designated for medical use. However, all the products available are manufactured by FDA Registered Entities and tested by independent third-party laboratories. Cannabis Suisse Corp's products are laboratory tested to ensure the end-users have access to a standardized, safe, and consistent product.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that
are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties, and other factors, which may cause the actual results, performance, or achievements of Cannabis Suisse Corp. to be materially different from the statements made herein.
CONTACT:
Alain Parrik
Cannabis Suisse Corp.
+41445865314
alain.parrik@cannabissuisse.biz
SOURCE: Cannabis Suisse Corp.
View source version on accesswire.com:
https://www.accesswire.com/655563/Cannabis-Suisse-Corp-Announces-the-Results-of-Laboratory-Testing-of-Its-New-Product-Line-and-Creation-the-LEARN-Section-on-the-Website
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Camino Announces C$5.6 Million Investment with Strategic Investors12.11.2025 12:00:00 CET | Press release
Not for distribution to United States newswire services or for release publication, distribution or dissemination, directly or indirectly, in whole or in part, in or into the United States. VANCOUVER, BC / ACCESS Newswire / November 12, 2025 / Camino Minerals Corporation (TSXV:COR)(OTCID:CAMZF) ("Camino" or the "Company") is pleased to announce that it is arranging a non-brokered private placement to raise total gross proceeds of approx. C$5.6 Million (the "Financing"). The Financing will consist of the issuance of 15,554,666 common shares of the Company (each a "Share") at a price per Share of C$0.36. Participants in the financing will include two significant new shareholders, EMX Royalty Corp. ("EMX") and Continental General Insurance Company ("CGIC"). Based in Austin, Texas, CGIC is one of the largest shareholders of Camino's partner, Nittetsu Mining. CGIC is a life and health insurance company founded in 1961, and is an active investor in producing and development-stage mining asse
Xsens Announces New Xsens Link for Motion Capture Across Humanoid Robotics, Health, Sports, and Entertainment12.11.2025 10:00:00 CET | Press release
Next-Generation motion capture from Xsens combines smarter sensors, seamless connectivity, and adaptive design to deliver precise, real-world motion data. ENSCHEDE, NL / ACCESS Newswire / November 12, 2025 / Xsens, a Movella brand and world leader in inertial motion capture technology, today announced the launch of the next-generation Xsens Link, an all-new motion capture system that redefines accuracy, usability, and versatility for users across industries. Redesigned from the ground up, the new Xsens Link delivers superior comfort, smarter data output, and minimal maintenance, empowering users to capture motion data with unprecedented speed and fidelity - whether in a robotics lab, film studio, or on the training field. "We've taken everything our customers love about Xsens and built the next generation around comfort, consistency, and flexibility," says Dennis Kloppenburg, product manager at Xsens. "From animators to athletes to robotics developers and researchers, The new Link deli
Air T Welcomes Creditor Support for Rex Acquisition11.11.2025 23:00:00 CET | Press release
MINNEAPOLIS, MINNESOTA / ACCESS Newswire / November 11, 2025 / Air T, Inc. (NASDAQ:AIRT) is pleased to announce that a majority of Rex's creditors-both in number and in value-have voted in favor of our bid to acquire Rex at the second meeting of creditors held on 11 November 2025. This strong endorsement reflects confidence in our vision for Rex and our commitment to regional aviation in Australia. We take our responsibilities under the proposed Deed of Company Arrangement seriously. We understand the Administrators intend to close the transaction by year-end, and we are working closely with all parties to ensure a smooth and timely completion. Air T is grateful for the support shown throughout this process and looks forward to finalizing the acquisition and beginning a new chapter for Rex and regional communities across Australia. NOTE REGARDING STAKEHOLDER QUESTIONS If you have questions related to this release or other Air T matters, please use our interactive Q&A capability, throug
MicroVision Announces Third Quarter 2025 Results11.11.2025 22:05:00 CET | Press release
REDMOND, WASHINGTON / ACCESS Newswire / November 11, 2025 / MicroVision, Inc. (NASDAQ:MVIS), a technology pioneer delivering advanced perception solutions in autonomy and mobility, today announced its third quarter 2025 results. Key Business and Operational Highlights Appointed 30-year industry veteran Glen DeVos as Chief Executive Officer, elevating automotive capabilities. Introduced next generation solid-state lidar sensor, MOVIA S, offering an energy-efficient and cost-effective short-range solution for a wide variety of automotive, industrial, and defense sector applications. Launched industry-disrupting Tri-Lidar Architecture solution, offering an alternative to the lidar industry's myopic focus on single sensor solutions. Executed agreement to acquire Scantinel Photonics, a German developer of long-range FMCW lidar, joining investment and strategic partners in advancing lidar-on-chip solution for commercial vehicle and passenger car markets. Established design office and testing
Climate Goals Threatened by Industrialised Animal Farming, Reveals Key International Study11.11.2025 15:20:00 CET | Press release
LONDON, UK / ACCESS Newswire / November 11, 2025 / A new study in Animals highlights that industrialized animal farming is one of the most powerful - yet persistently neglected - forces driving the climate and biodiversity crises. The analysis, "The Missing Target: Why Industrialized Animal Farming Must Be at the Core of the Climate Agenda," synthesizes evidence from 47 international studies and concludes that reducing livestock production and embracing plant-based food systems is essential for meeting global climate goals. Major Insights Across global research, livestock farming contributes an estimated 12-20% of all greenhouse gas emissions annually, with the most comprehensive studies yielding the highest figures. The most modern accounting methods, which include the impacts of deforestation, bottom trawling and cooling effects from certain atmospheric pollutants, reveal that 52% of present-day global warming is attributable to animal agriculture. Animal agriculture occupies over 80
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom